The Limits of Acute Anemia

Area of Science:

• Transfusion Medicine
• Critical Care Medicine
• Hematology

Background:

• Historically, a hemoglobin threshold of <10 g/dL guided red blood cell (RBC) transfusions.
• Recent evidence suggests lower hemoglobin levels can be tolerated acutely without adverse effects.
• However, mild or moderate anemia is linked to long-term morbidity and mortality, creating a clinical paradox.

Purpose of the Study:

• To explore the physiological limits of acute anemia.
• To reconcile short-term tolerance with long-term risks of anemia.
• To introduce Patient Blood Management (PBM) as a clinical strategy.

Main Methods:

• Review of physiological anemia limits.
• Analysis of clinical evidence regarding anemia thresholds.
• Presentation of PBM principles and application in intensive care units (ICUs).

Main Results:

• Acute, severe anemia can be survived short-term.
• Chronic or moderate anemia poses significant long-term health risks.
• PBM addresses anemia prevention and optimizes RBC transfusion practices.

Conclusions:

• Avoiding acute anemia and managing underlying causes are crucial.
• Patient Blood Management (PBM) is a key therapeutic concept for preventing anemia and unnecessary RBC transfusions.
• PBM implementation is vital for high-quality patient care in ICUs.